comparemela.com

Latest Breaking News On - Earth therapeutics - Page 4 : comparemela.com

Blue Earth Therapeutics Announces U S FDA Clearance for Investigational New Drug (IND) Application for 177Lu-rhPSMA-10 1

Blue Earth Therapeutics Announces U S FDA Clearance for Investigational New Drug (IND) Application

− 177Lutetium-labelled radiohybrid Prostate-Specific Membrane Antigen (177Lu-rhPSMA-10.1) is a highly optimized, next generation therapeutic radiopharmaceutical −− Newly launched Blue Earth Therapeutics rapidly advancing lead candidate into Phase 1/2 clinical development –OXFORD, United Kingdom & BURLINGTON, Mass. .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.